{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:38:27Z","timestamp":1793140707866,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI","award":["Cancer Center Support Grant P30 CA008748"],"award-info":[{"award-number":["Cancer Center Support Grant P30 CA008748"]}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018854","name":"Sirtex Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["Imaging"],"award-info":[{"award-number":["Imaging"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["Radiation Sciences Program award"],"award-info":[{"award-number":["Radiation Sciences Program award"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00270-024-03870-2","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T17:02:04Z","timestamp":1729011724000},"page":"1461-1470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Systemic Immunological Changes After Yttrium-90 Radioembolization: A Pilot Prospective Observational Study\u2014Clinical Insights"],"prefix":"10.1007","volume":"47","author":[{"given":"Yuliya","family":"Kitsel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasios","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efsevia","family":"Vakiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Platon M.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3142-1399","authenticated-orcid":false,"given":"Constantinos T.","family":"Sofocleous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"3870_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00411-013-0497-2","volume":"53","author":"M Orth","year":"2014","unstructured":"Orth M, Lauber K, Niyazi M, et al. Current concepts in clinical radiation oncology. Radiat Environ Biophys. 2014;53:1\u201329.","journal-title":"Radiat Environ Biophys"},{"key":"3870_CR2","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1200\/JCO.2014.55.4675","volume":"32","author":"RD Timmerman","year":"2014","unstructured":"Timmerman RD, Herman J, Cho LC. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol. 2014;32:2847\u201354.","journal-title":"J Clin Oncol"},{"key":"3870_CR3","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/annonc\/mds236","volume":"23","author":"H Schmoll","year":"2012","unstructured":"Schmoll H, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making. Ann Oncol. 2012;23:2479\u2013516.","journal-title":"Ann Oncol."},{"key":"3870_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network. 2021;19:329\u201359.","journal-title":"J Natl Compr Cancer Network"},{"key":"3870_CR5","doi-asserted-by":"publisher","first-page":"37912","DOI":"10.18632\/oncotarget.16007","volume":"8","author":"MS Dendy","year":"2017","unstructured":"Dendy MS, Ludwig JM, Kim HS. Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis. Oncotarget. 2017;8:37912\u201322.","journal-title":"Oncotarget"},{"key":"3870_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","volume":"34","author":"GA van Hazel","year":"2016","unstructured":"van Hazel GA, Heinemann V, Sharma NK, et al. SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34:1723\u201331.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3870_CR7","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1200\/JCO.21.01839","volume":"39","author":"MF Mulcahy","year":"2021","unstructured":"Mulcahy MF, Mahvash A, Pracht M, et al. Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial. J Clin Oncol Off J Am Soc Clin Oncol. 2021;39:3897\u2013907.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3870_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","volume":"18","author":"HS Wasan","year":"2017","unstructured":"Wasan HS, Gibbs P, Sharma NK, et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol. 2017;18:1159\u201371.","journal-title":"Lancet Oncol"},{"key":"3870_CR9","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3390\/cells11233826","volume":"11","author":"KP Fabian","year":"2022","unstructured":"Fabian KP, Kowalczyk JT, Reynolds ST, Hodge JW. Dying of stress: chemotherapy, radiotherapy, and small-molecule inhibitors in immunogenic cell death and immunogenic modulation. Cells. 2022;11:3826.","journal-title":"Cells"},{"key":"3870_CR10","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1158\/1078-0432.CCR-22-2176","volume":"29","author":"MB Foote","year":"2023","unstructured":"Foote MB, Argil\u00e9s G, Rousseau B, Segal NH. Facts and hopes in colorectal cancer immunotherapy. Clin Cancer Res Off J Am Assoc Cancer Res. 2023;29:4032\u20139.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3870_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.728018","volume":"11","author":"KP Fabian","year":"2021","unstructured":"Fabian KP, Wolfson B, Hodge JW. from immunogenic cell death to immunogenic modulation: select chemotherapy regimens induce a spectrum of immune-enhancing activities in the tumor microenvironment. Front Oncol. 2021;11: 728018.","journal-title":"Front Oncol"},{"key":"3870_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2020.00369","volume":"11","author":"E Picard","year":"2020","unstructured":"Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol. 2020;11:369.","journal-title":"Front Immunol"},{"key":"3870_CR13","doi-asserted-by":"publisher","first-page":"1022190","DOI":"10.3389\/fimmu.2022.1022190","volume":"13","author":"J Yuan","year":"2022","unstructured":"Yuan J, Li J, Gao C, Jiang C, Xiang Z, Wu J. Immunotherapies catering to the unmet medical need of cold colorectal cancer. Front Immunol. 2022;13:1022190.","journal-title":"Front Immunol"},{"key":"3870_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","volume":"366","author":"MA Postow","year":"2012","unstructured":"Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366:925\u201331.","journal-title":"N Engl J Med"},{"key":"3870_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2217\/imt-2019-0105","volume":"11","author":"E Garelli","year":"2019","unstructured":"Garelli E, Rittmeyer A, Putora PM, Glatzer M, Dressel R, Andreas S. Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy. 2019;11:1445\u201361.","journal-title":"Immunotherapy"},{"key":"3870_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40425-019-0692-z","volume":"7","author":"X Liu","year":"2019","unstructured":"Liu X, Yao J, Song L, Zhang S, Huang T, Li Y. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade. J Immunother Cancer. 2019;7:204.","journal-title":"J Immunother Cancer"},{"key":"3870_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/02841860600604611","volume":"45","author":"PJ Wers\u00e4ll","year":"2006","unstructured":"Wers\u00e4ll PJ, Blomgren H, Pisa P, Lax I, K\u00e4lkner KM, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 2006;45:493\u20137.","journal-title":"Acta Oncol"},{"key":"3870_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cellimm.2015.09.011","volume":"299","author":"S Ostrand-Rosenberg","year":"2016","unstructured":"Ostrand-Rosenberg S. Tolerance and immune suppression in the tumor microenvironment. Cell Immunol. 2016;299:23\u20139.","journal-title":"Cell Immunol"},{"key":"3870_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","volume":"10","author":"SC Formenti","year":"2009","unstructured":"Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10:718\u201326.","journal-title":"Lancet Oncol"},{"key":"3870_CR20","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28518","volume":"3","author":"EB Golden","year":"2014","unstructured":"Golden EB, Frances D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti SC. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014;3: e28518.","journal-title":"Oncoimmunology"},{"key":"3870_CR21","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1158\/2326-6066.CIR-18-0793","volume":"7","author":"JW Welsh","year":"2019","unstructured":"Welsh JW, Tang C, de Groot P, et al. Phase II trial of ipilimumab with stereotactic radiation therapy for metastatic disease: outcomes, toxicities, and low-dose radiation-related abscopal responses. Cancer Immunol Res. 2019;7:1903\u20139.","journal-title":"Cancer Immunol Res"},{"key":"3870_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fonc.2018.00612","volume":"8","author":"ZS Buchwald","year":"2018","unstructured":"Buchwald ZS, Wynne J, Nasti TH, et al. Radiation, immune checkpoint blockade and the abscopal effect: a critical review on timing. Dose and Fractionation Front Oncol. 2018;8:612.","journal-title":"Dose and Fractionation Front Oncol"},{"key":"3870_CR23","first-page":"8466","volume":"63","author":"S Teitz-Tennenbaum","year":"2003","unstructured":"Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Can Res. 2003;63:8466\u201375.","journal-title":"Can Res"},{"issue":"1","key":"3870_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijrobp.2023.11.023","volume":"119","author":"TNT Uong","year":"2023","unstructured":"Uong TNT, Yoon M, Chung IJ, et al. Direct tumor irradiation potentiates adoptive NK cell targeting against parental and stem-like cancer in human liver cancer models. Int J Radiat Oncol Biol Phys. 2023;119(1):234\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3870_CR25","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/jnci\/djad118","volume":"115","author":"L Karapetyan","year":"2023","unstructured":"Karapetyan L, Iheagwara UK, Olson AC, Chmura SJ, Skinner HK, Luke JJ. Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations. J Natl Cancer Inst. 2023;115:1278\u201393.","journal-title":"J Natl Cancer Inst"},{"key":"3870_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark Res. 2020;8:49.","journal-title":"Biomark Res"},{"key":"3870_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41:843\u201352.","journal-title":"Immunity"},{"key":"3870_CR28","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37:11553\u201372.","journal-title":"Tumour Biol"},{"key":"3870_CR29","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1245\/s10434-023-13527-y","volume":"30","author":"T Yamamoto","year":"2023","unstructured":"Yamamoto T, Tsunedomi R, Nakajima M, et al. IL-6 Levels correlate with prognosis and immunosuppressive stromal cells in patients with colorectal cancer. Ann Surg Oncol. 2023;30:5267\u201377.","journal-title":"Ann Surg Oncol"},{"key":"3870_CR30","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3748\/wjg.v11.i11.1639","volume":"11","author":"NI Nikiteas","year":"2005","unstructured":"Nikiteas NI, Tzanakis N, Gazouli M, et al. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol. 2005;11:1639\u201343.","journal-title":"World J Gastroenterol"},{"key":"3870_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00384-009-0818-8","volume":"25","author":"H Kn\u00fcpfer","year":"2010","unstructured":"Kn\u00fcpfer H, Preiss R. Serum interleukin-6 levels in colorectal cancer patients\u2013a summary of published results. Int J Colorectal Dis. 2010;25:135\u201340.","journal-title":"Int J Colorectal Dis"},{"key":"3870_CR32","first-page":"1910","volume":"50","author":"YC Chung","year":"2003","unstructured":"Chung YC, Chang YF. Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology. 2003;50:1910\u20133.","journal-title":"Hepatogastroenterology"},{"key":"3870_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/clim.2001.5163","volume":"102","author":"G Galizia","year":"2002","unstructured":"Galizia G, Orditura M, Romano C, et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol. 2002;102:169\u201378.","journal-title":"Clin Immunol"},{"key":"3870_CR34","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00270-017-1622-4","volume":"40","author":"M Seidensticker","year":"2017","unstructured":"Seidensticker M, Powerski M, Seidensticker R, et al. Cytokines and (90)Y-radioembolization: relation to liver function and overall survival. Cardiovasc Intervent Radiol. 2017;40:1185\u201395.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3870_CR35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jfma.2020.09.005","volume":"120","author":"CA Liu","year":"2021","unstructured":"Liu CA, Lee IC, Lee RC, Chen JL, Chao Y, Hou MC, Huang YH. Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres. J Formos Med Assoc. 2021;120:1127\u201336.","journal-title":"J Formos Med Assoc"},{"key":"3870_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1148\/radiol.220158","volume":"306","author":"AR Deipolyi","year":"2023","unstructured":"Deipolyi AR, Johnson CB, Riedl CC, et al. Prospective evaluation of immune activation associated with response to radioembolization assessed with PET\/CT in women with breast cancer liver metastasis. Radiology. 2023;306:279\u201387.","journal-title":"Radiology"},{"key":"3870_CR37","doi-asserted-by":"publisher","first-page":"1175513","DOI":"10.3389\/fimmu.2023.1175513","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Chen F, Gao H, et al. Cytokine concentration in peripheral blood of patients with colorectal cancer. Front Immunol. 2023;14:1175513.","journal-title":"Front Immunol"},{"key":"3870_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41590-022-01176-4","volume":"23","author":"C Guy","year":"2022","unstructured":"Guy C, Mitrea DM, Chou PC, et al. LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation. Nat Immunol. 2022;23:757\u201367.","journal-title":"Nat Immunol"},{"key":"3870_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12967-022-03646-7","volume":"20","author":"D Shao","year":"2022","unstructured":"Shao D, Chen Y, Huang H, et al. LAG3 blockade coordinates with microwave ablation to promote CD8(+) T cell-mediated anti-tumor immunity. J Transl Med. 2022;20:433.","journal-title":"J Transl Med"},{"key":"3870_CR40","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jvir.2017.10.007","volume":"29","author":"AR Deipolyi","year":"2018","unstructured":"Deipolyi AR, Bromberg JF, Erinjeri JP, Solomon SB, Brody LA, Riedl CC. Abscopal effect after radioembolization for metastatic breast cancer in the setting of immunotherapy. J Vas Interv Radiol. 2018;29:432\u20133.","journal-title":"J Vas Interv Radiol"},{"key":"3870_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100948","volume":"7","author":"RI Chin","year":"2022","unstructured":"Chin RI, Bommireddy A, Fraum TJ, et al. clinical outcomes of patients with unresectable primary liver cancer treated with Yttrium-90 radioembolization with an escalated dose. Adv Radiat Oncol. 2022;7: 100948.","journal-title":"Adv Radiat Oncol"},{"key":"3870_CR42","first-page":"1616","volume":"62","author":"AA Alsultan","year":"2021","unstructured":"Alsultan AA, van Roekel C, Barentsz MW, et al. Dose-response and dose-toxicity relationships for glass (90)Y radioembolization in patients with liver metastases from colorectal cancer. J Nucl Med Off Publ Soc Nucl Med. 2021;62:1616\u201323.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"3870_CR43","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1007\/s00261-021-02956-6","volume":"46","author":"I Kurilova","year":"2021","unstructured":"Kurilova I, Bendet A, Fung EK, et al. Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres. Abdom Radiol (NY). 2021;46:3428\u201336.","journal-title":"Abdom Radiol (NY)"},{"key":"3870_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jvir.2022.12.021","volume":"34","author":"AM Chiu","year":"2023","unstructured":"Chiu AM, Savoor R, Gordon AC, et al. Yttrium-90 radiation segmentectomy in oligometastatic secondary hepatic malignancies. J Vasc Interv Radiol JVIR. 2023;34:362\u20138.","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"3870_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jso.26223","volume":"123","author":"SA Padia","year":"2021","unstructured":"Padia SA, Johnson GE, Agopian VG, DiNorcia J, Srinivasa RN, Sayre J, Shin DS. Yttrium-90 radiation segmentectomy for hepatic metastases: a multi-institutional study of safety and efficacy. J Surg Oncol. 2021;123:172\u20138.","journal-title":"J Surg Oncol"},{"key":"3870_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40658-022-00520-9","volume":"10","author":"J OrcajoRinc\u00f3n","year":"2023","unstructured":"OrcajoRinc\u00f3n J, Regi AR, Pe\u00f1a AM, et al. Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma. EJNMMI Phys. 2023;10:7.","journal-title":"EJNMMI Phys"},{"key":"3870_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","volume":"79","author":"A Riaz","year":"2011","unstructured":"Riaz A, Gates VL, Atassi B, et al. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys. 2011;79:163\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3870_CR48","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.3390\/cancers13194908","volume":"13","author":"T Sankhla","year":"2021","unstructured":"Sankhla T, Cheng B, Nezami N, et al. Role of resin microsphere Y90 dosimetry in predicting objective tumor response, survival and treatment related toxicity in surgically unresectable colorectal liver metastasis: a retrospective single institution study. Cancers (Basel). 2021;13:4908.","journal-title":"Cancers (Basel)"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-024-03870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-024-03870-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-024-03870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T17:04:07Z","timestamp":1730912647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-024-03870-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3870"],"URL":"https:\/\/doi.org\/10.1007\/s00270-024-03870-2","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No other authors have any conflict of interest disclosures related to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}